Therapeutic Classification: anti-infectives
Pharmacologic Classification: macrolides
Absorption: Minimal systemic absorption.
Distribution: Stays primarily in the GI tract.
Metabolism/Excretion: Mostly transformed via hydrolysis in the GI tract to OP-1118, its active metabolite. Eliminated mostly (>92%) in feces: <1% excreted in urine.
Half-Life: Fidaxomicin: 11.7 hr; OP-1118: 11.2 hr.